Stockscreener 앱 받기
0.0335
41.55%
-0.0233
Aditxt Inc 주식(ADTX)의 최신 뉴스
Crude Oil Falls 1%; Dollar General Posts Upbeat Sales - Benzinga
Nasdaq Down Over 100 Points; US Producer Inflation Stalls In February - Benzinga
ADTX stock plunges to 52-week low, touches $0.04 - Investing.com
US Stocks Likely To Open Lower After A Brief Respite: 'Add Exposure To Equities' Amid Pullback, Says Expert - Benzinga
Why Intel Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - Benzinga
Aditxt shares fall on 1-for-250 reverse stock split - MSN
Aditxt announces 1-for-250 reverse stock split By Investing.com - Investing.com Australia
Aditxt announces 1-for-250 reverse stock split effective March 17 - TipRanks
Aditxt announces 1-for-250 reverse stock split - Investing.com
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Aditxt, Inc. Announces Reverse Stock Split Plan - TipRanks
Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-250 Reverse Stock Split Effective at the Open of Trading on March 17, 2025 - Bluefield Daily Telegraph
Bulls Turn to Pennies STSS, ADTX, CSDX, SPRC, CBDW, YGTFF During Market Uncertainty – Small-Cap Stocks Poised for Big Moves - Financial Content
Aditxt advances autoimmune therapy ADI-100 toward trials By Investing.com - Investing.com Canada
Aditxt’s Adimune to ship substances for product formulation of of ADI-100 - TipRanks
Aditxt advances autoimmune therapy ADI-100 toward trials - Investing.com
Aditxt Subsidiary Adimune to Ship Drug Substances for Final Drug Product Formulation of ADI-100 Ahead of Planned Clinical Trials in Type 1 Diabetes and Psoriasis in Germany, and Stiff Person Syndrome at the Mayo Clinic in the U.S. - Quantisnow
Aditxt approves reverse stock split, adjourns special meeting By Investing.com - Investing.com Australia
Aditxt approves reverse stock split, adjourns special meeting - Investing.com India
Short Interest in Aditxt, Inc. (NASDAQ:ADTX) Expands By 638.6% - Defense World
Stocks Under $1: PMAX PRSO ARBB KAVL to Watch in March 2025 – More Stocks Inside - Financial Content
Aditx Therapeutics stock hits 52-week low at $0.07 By Investing.com - Investing.com Australia
Aditx Therapeutics stock hits 52-week low at $0.07 - Investing.com India
Is the Market Bullish or Bearish on Aditxt? - Benzinga
Such Is The Power Of Aditxt Inc (NASDAQ: ADTX) - Stocks Register
Aditxt Unveils Strategic Initiatives During Virtual Fireside Chat - Defense World
Financial Health Check: Examining Aditxt Inc (ADTX)’s Key Ratios - The Dwinnex
Aditxt, Inc. Discusses Pearsanta’s Planned IPO and Innovations - TipRanks
Top 5 Biotech Stocks That Saw Biggest Retail Following Jump Last Week - Asianet Newsable
Microcap Biotech Aditxt Rallies Retail Interest Ahead Of CEO’s Fireside Chat: What’s On Investors’ Radar? - Asianet Newsable
Aditxt subsidiary Persanta engages Dominary Securities for IPO - Yahoo Finance
Aditxt, Inc Subsidiary Pearsanta Engages Dominari Securities for its IPO By Investing.com - Investing.com Australia
Aditxt subsidiary Pearsanta prepares for IPO with lead underwriter By Investing.com - Investing.com Nigeria
Aditxt Subsidiary Pearsanta Engages Dominari Securities for its Initial Public Offering, to Drive U.S. and Global Commercial Launch of Early Cancer Detection and Diagnosis Targeted for H2 2025 - Lelezard
Aditxt Co's Unit Pearsanta Engaged Dominari Securities Llc As Lead Underwriter For Pearsanta's Planned IPO - Marketscreener.com
Aditxt, Inc Subsidiary Pearsanta Engages Dominari Securities for its IPO - Investing.com India
Aditxt subsidiary Pearsanta prepares for IPO with lead underwriter - Investing.com
Can This New DNA Cancer Test Disrupt the $20B Diagnostics Market? Pearsanta Unveils IPO Plans - StockTitan
Why Global Blue Group Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket - Benzinga
ADTX Stock Earnings: Aditxt Reported Results for Q1 2024 - MSN
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Why GCL Global Holdings Shares Are Trading Higher By Around 107%; Here Are 20 Stocks Moving Premarket - Benzinga
5.68%
0.28%
자본화:
|
볼륨(24시간):